Effects of Micronized Progesterone in Menopausal Hormone Replacement Therapy on Sleep
Journal of Obstetrics and Gynaecology Research · 2026-07 · 52 (7)
DOI: 10.1111/jog.70401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 15.07.2026. Verfasst von Asuka Hirose und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Institute of Science Tokyo Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Progesterone, Sleep Initiation and Maintenance Disorders, Sleep, Progestins. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
In Japan, only synthetic progestins were available for menopausal hormone therapy until 2021. Since then, micronized progesterone has become available. Micronized progesterone binds to gamma‐aminobutyric acid type A receptors and exerts sedative and hypnotic effects. This study evaluated the effects of micronized progesterone on sleep in women receiving estrogen‐progestogen therapy.
Methods
This retrospective study was approved by the institutional review board. Eligible participants were women who switched from synthetic progestins to micronized progesterone between December 2022 and September 2024. Women using sleep medications were excluded. Sleep quality was assessed using the Athens Insomnia Scale before switching, 3 months, and 1 year after initiating micronized progesterone. Progesterone was administered cyclically or continuously. In cyclic users, the Insomnia Severity Index was used to compare sleep during treatment and treatment‐free phases.
Results
A total of 36 participants were included, of whom 22 completed a 1‐year follow‐up. At 3 months, sleep induction ( p = 0.002) and awakenings during the night ( p = 0.028) on the Athens Insomnia Scale improved, although the total score remained unchanged. At 1 year, no significant changes were observed. Among 11 participants with baseline scores ≤ 3, the total Athens Insomnia Scale scores significantly worsened at 3 months and 1 year. No significant differences in Insomnia Severity Index scores were observed between treatment and non‐treatment periods.
Conclusions
Micronized progesterone improved sleep induction and reduced awakenings during the night at 3 months; however, benefits diminished by 1 year. Sleep conditions worsened in women without preexisting sleep disorders. Regular monitoring is recommended during long‐term micronized progesterone therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Institute of Science Tokyo Hospital, Tokyo, Japan.
- Department of Gynecology, Kyoundo Hospital, Tokyo, Japan.
ORCID-Profile: Asuka Hirose, Masakazu Terauchi, Naoyuki Miyasaka
Zitieren
APA
Hirose, A., Terauchi, M., Hirata, M., Matsuoka, K., Umayahara, K., Sakamoto, M., & Miyasaka, N. (2026). Effects of Micronized Progesterone in Menopausal Hormone Replacement Therapy on Sleep. Journal of Obstetrics and Gynaecology Research, 52(7). https://doi.org/10.1111/jog.70401
Vancouver
Hirose A, Terauchi M, Hirata M, Matsuoka K, Umayahara K, Sakamoto M, et al. Effects of Micronized Progesterone in Menopausal Hormone Replacement Therapy on Sleep. Journal of Obstetrics and Gynaecology Research. 2026;52(7). doi:10.1111/jog.70401
BibTeX
@article{Hirose2026,
author = {Hirose, Asuka and Terauchi, Masakazu and Hirata, Momo and Matsuoka, Kazuko and Umayahara, Kenji and Sakamoto, Masaru and Miyasaka, Naoyuki},
title = {Effects of Micronized Progesterone in Menopausal Hormone Replacement Therapy on Sleep},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
volume = {52},
number = {7},
doi = {10.1111/jog.70401}
}
EUVIMED